Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma
- 1 February 1991
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 2, 43-47
- https://doi.org/10.1093/annonc/2.suppl_2.43
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease.Journal of Clinical Oncology, 1988
- Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemiaBlood, 1988
- High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemiaBlood, 1987
- Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.The Journal of Experimental Medicine, 1987
- The Human Interleukin-2 Receptor: Normal and Abnormal Expression in T Cells and in Leukemias Induced by the Human T-Lymphotropic RetrovirusesAnnals of Internal Medicine, 1986
- A multivariate analysis of prognostic factors in early stage hodgkin's diseaseInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's diseaseBritish Journal of Cancer, 1984
- Direct demonstration of the identity of T cell growth factor binding protein and the Tac antigen.The Journal of Experimental Medicine, 1983